Skip to content

Clinical trials

Hematologic Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Country / region: Switzerland Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20091
20101
20121
20131
20161
20171
20181
20202
20213
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting6
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Merck Sharp & Dohme LLC2
University Hospital, Basel, Switzerland2
Amgen1
Centre Hospitalier Universitaire Vaudois1
Cogent Biosciences, Inc.1
Glycostem Therapeutics BV1
Kite, A Gilead Company1
Mundipharma Research Limited1
Prelude Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms18
Hematologic Diseases3
Leukemia3
Leukemia, Myeloid, Acute3
Neoplasms3
Bone Marrow Diseases2
Leukemia, Myeloid2
Leukemia, Myelomonocytic, Chronic2
Lymphoma, Large B-Cell, Diffuse2
Multiple Myeloma2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.